Temodar Shortage Update: What Patients Need to Know in 2026

For patients with glioblastoma multiforme (GBM) or anaplastic astrocytoma, Temodar (temozolomide) is not optional — it is a cornerstone of their cancer treatment. Supply disruptions to this medication carry life-or-death stakes. Here is what patients need to know about Temodar's supply status in 2026.

Current Supply Status: Oral vs. IV Temozolomide

There are two formulations of temozolomide — oral capsules and intravenous (IV) injection. Their supply situations differ significantly in 2026:

Oral generic temozolomide: Generally available from multiple manufacturers. Teva, Sun Pharma, Dr. Reddy's, and Amneal all produce oral capsules, creating a redundant supply chain that buffers against single-manufacturer disruptions. Most patients on maintenance therapy should be able to obtain oral temozolomide through their specialty pharmacy.

IV temozolomide (for injection): This formulation has appeared on institutional shortage lists in oncology pharmacy surveys. IV temozolomide is used when patients cannot swallow capsules (e.g., during surgical recovery or severe nausea). Availability can vary by region and institution.

Brand Temodar: The branded version by Merck is not widely stocked at retail pharmacies. It is typically dispensed through specialty pharmacy or oncology clinic channels and is generally not the first-choice product for cost reasons.

Why Does Temozolomide Face Supply Challenges?

Understanding why shortages happen helps patients anticipate and navigate them. The main drivers include:

Specialty drug routing complexity: Temozolomide flows through specialty pharmacy channels rather than traditional retail networks. When a specialty pharmacy has a supply problem, patients often have limited alternatives.

Manufacturing issues: Like many generics, temozolomide is manufactured in overseas facilities. API (active pharmaceutical ingredient) sourcing issues or facility problems can disrupt supply temporarily.

Oncology drug shortage patterns: IV temozolomide has historically appeared alongside other oncology drugs (vincristine, carboplatin, etc.) on shortage lists. The oncology drug shortage crisis in the United States affects multiple antineoplastic agents at once.

Tariff and trade disruption: April 2025 tariffs on pharmaceutical imports from India and China have raised costs for generic manufacturers and may affect supply chain reliability going forward.

How to Protect Your Supply of Temodar

Given the stakes, patients on temozolomide should be proactive:

Submit your prescription to the pharmacy 7–10 days before each cycle begins — don't wait until the last minute.

Ask your oncologist's office to confirm availability before each cycle. Clinic pharmacists often know which specialty pharmacies have stock.

Ask about generic temozolomide — if your current pharmacy is out of one manufacturer's product, they may be able to source from a different manufacturer.

Keep a list of backup specialty pharmacies that dispense temozolomide in your area. Your oncology clinic pharmacist can help you build this list.

Where to Check Current Shortage Status

The following official sources track drug shortage status:

FDA Drug Shortages Database — the official government list of current drug shortages

ASHP Drug Shortages Resource Center — American Society of Health-System Pharmacists; often has more current information

You can also use medfinder to check which pharmacies near you currently have your specific temozolomide strength in stock. medfinder contacts pharmacies on your behalf and texts you the results — a critical service when time is limited and treatment cannot wait.

38,717+ patients found their medications in stock

38K+

Find Temodar In Stock Today →

What to Do If You Learn of a Shortage

If you hear that temozolomide is entering a shortage period:

Don't panic — act. Contact your oncology team and your specialty pharmacy immediately.

Ask whether your next supply can be secured in advance.

Ask your oncologist if any treatment adjustments are appropriate given potential supply uncertainty.

Also read: Alternatives to Temodar If You Can't Fill Your Prescription